Recent News

• 10.06.2025 - Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
• 10.06.2025 - Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
• 09.24.2025 - Shareholders of Verona Pharma Approve Proposed Acquisition by Merck
• 09.24.2025 - Shareholders of Verona Pharma Approve Proposed Acquisition by Merck
• 09.16.2025 - Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
• 09.16.2025 - Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025

Recent Filings

• 09.24.2025 - EX-99.1 EX-99.1
• 09.24.2025 - 8-K Current report
• 09.11.2025 - DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
• 09.10.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 09.09.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 09.09.2025 - 8-K Current report
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.18.2025 - DEFM14A Definitive proxy statement relating to merger or acquisition